JPRN-UMIN000031976
Completed
N/A
Exploratory Study of Genetic Factors Related to the Inhibitory Effect of Tolvaptan on Increased Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney Disease - To explore genome biomarkers for Tolvaptan efficacy in ADPKD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Autosomal Dominant Polycystic Kidney Disease
- Sponsor
- Otsuka Pharmaceutical Co.,Ltd.
- Enrollment
- 890
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who did not participate in extension Trial(Refer to ClinicalTrials.gov:NCT01280721 or NCT01214421\)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
The study of investigating the genetic profiles of Exceptional Response in cancer therapies.Cancer patient who received therapies.JPRN-UMIN000016643ational Cancer Center Hospital30
Completed
N/A
A study to improve our understanding of the genetic causes of swelling in babies before birthFetal oedema/hydrops with a focus on lymphatic related hydropsPregnancy and ChildbirthConditions involving the integument and temperature regulation of fetus and newbornISRCTN22076461St George’s University Hospitals NHS Foundation Trust60
Not Yet Recruiting
N/A
Study on genetic factors in the pathogenesis of Inflammatory Bowel Disease: Gathering a matched control populatioCrohns diseaseUlcerative Colitis1001796910003816NL-OMON30241Academisch Medisch Centrum3,000
Completed
Phase 4
Investigation of Genetic Predictors of the Response to Selective Serotonin Re-Uptake Inhibitors TreatmentDepressionAntidepressantTreatment predictionMental Health - DepressionACTRN12609000295246Tartu University135
Completed
N/A
Exploratory research on genetic factors in the metabolism and mechanism of action of citrulline involved in vascular agingJPRN-UMIN000048828DeNA Life Science Inc.2,000